| 25-OH Vitamin D | 40–60 ng/mL | Severe deficiency doubles dementia risk |
Detail →
|
| A1c + fasting glucose context review | Interpret with timing pattern | Focused explainer for the common mismatch where average labs look normal but the symptom timing still suggests glucose variability. |
Detail →
|
| AASP Sensory Profile | Validated assessment | Adult sensory processing patterns |
Detail →
|
| Actigraphy | 7+ days tracking | Wrist-worn sleep tracker — assesses circadian patterns |
Detail →
|
| Active B12 (Holotranscobalamin) | >50 pmol/L | More accurate than serum B12 for cellular deficiency |
Detail →
|
| AM Cortisol (8am) | Lab reference interval with timing context | Morning cortisol explainer focused on the timed 8am draw clinicians usually use for baseline adrenal-context questions. |
Detail →
|
| ANA (Antinuclear Antibodies) | Negative (<1:40) | Screening for autoimmune disease — positive in lupus, Sjögren's, RA |
Detail →
|
| Anti-dsDNA Antibodies | Negative | Specific for systemic lupus erythematosus (SLE) |
Detail →
|
| Anticholinergic Burden Score | 0 (none) | Score >3 associated with cognitive decline |
Detail →
|
| AQ-10 Screening | Score <6 | Autism spectrum screening questionnaire |
Detail →
|
| ASL-MRI (Arterial Spin Labeling) | Normal perfusion | Non-invasive brain blood flow measurement |
Detail →
|
| ASRS-v1.1 (ADHD) | 0-6 screener context | Patient-facing ADHD screener route matching the ASRS-v1.1 wording used in results cards and clinician conversations. |
Detail →
|
| ASRS-v1.1 Screener | Validated questionnaire | Adult ADHD Self-Report Scale — 6-question screener |
Detail →
|
| Bartonella IgG/IgM | Negative | Bartonella infection screening |
Detail →
|
| Bartonella PCR | Negative | Direct detection of Bartonella DNA |
Detail →
|
| Baseline Cognitive Assessment | Screening context | Patient-facing explainer for starting with a validated cognitive screen such as MoCA before deciding whether fuller neuropsychology is needed. |
Detail →
|
| Beighton Score | <5/9 | Joint hypermobility assessment for EDS/HSD |
Detail →
|
| Blood Mercury | <5 μg/L | Mercury exposure — half-life ~70-80 days. Primarily reflects recent dietary/fish exposure. |
Detail →
|
| Blood Sugar Assessment | Panel context | Starter metabolic workup for glucose variability, reactive hypoglycemia clues, and insulin-resistance overlap. |
Detail →
|
| Brain MRI | Radiology report | Structural neuroimaging used to evaluate red flags and differential neurological causes. |
Detail →
|
| BRIEF-A | T-score <65 | Behavior Rating Inventory of Executive Function |
Detail →
|
| C-Reactive Protein | <3.0 mg/L | General inflammation marker — less sensitive than hs-CRP |
Detail →
|
| C4a Complement | <2830 ng/mL | Inflammatory marker elevated in CIRS and Lyme |
Detail →
|
| CBC + CMP | Lab reference interval | Baseline panel combining complete blood count and metabolic chemistry for broad screening context. |
Detail →
|
| CBC with Differential | Lab reference interval | Core blood count panel used to review white cell patterns, hemoglobin, and platelet context. |
Detail →
|